Skip to content

Lexicon Pharmaceuticals LXRX Change in Inventories

Change in Inventories at other companies

Eli Lilly logo
Eli LillyLLY
$1.17B+86.3%
Pfizer logo
PfizerPFE
-$140.25M-166%
Merck & Co. logo
Merck & Co.MRK
$295M+41.3%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$97.7M-41.5%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$185K-9.8%
Cytokinetics logo
CytokineticsCYTK

Other financials

Income statement

See full
Revenue$21.1M+1,572%
Gross profit$21.0M+1,604%
Operating income-$996.0K+96.1%
Net income-$1.0M+95.9%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$67.1M+6.7%
Total debt$57.7M-45.7%
Total equity$202.9M+64.9%
Total assets$268.8M-9.7%

Cash flow

See full
Operating cash flow-$14.7M+66.4%
CapEx--100%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$986.12M+273%
Enterprise value$976.73M+219%
P/S14.2×+5.7×

Profitability

See full
Gross margin99.5%+1.5pp
Operating margin-34.8%-16.8pp
Net margin-37.5%-18.1pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-16%-7.2pp
Debt / equity0.3×-0.6×
Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lexicon Pharmaceuticals's change in inventories?
Lexicon Pharmaceuticals (LXRX) reported change in inventories of -$5K in Q1 2026.
How has Lexicon Pharmaceuticals's change in inventories changed year-over-year?
Lexicon Pharmaceuticals's change in inventories increased by 83.3% year-over-year, from -$30K to -$5K.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.